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Quality measures are increasingly reported by hospitals to the Centers
for Medicare andMedicaid Services (CMS), yet there may be tradeoffs
in performance between infection control (IC) and other quality
measures. Hospitals that performed best on IC measures did not
perform well on most CMS non–IC quality measures.
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In response to the movement toward patient-centered care,
quality measures are increasingly being reported by hospitals
to the Centers for Medicare and Medicaid Services (CMS).
The CMS Hospital Compare website provides information
regarding the quality of care at more than 4,000 hospitals and
includes more than 120 measures.1 While tools such as
Hospital Compare provide valuable information to healthcare
consumers, providers, and administrators, there is concern
that the metrics may not be consistent and that some may not
provide an accurate depiction of quality in the institution.2
Furthermore, the CMS Value-Based Purchasing (VBP) pro-
gram rewards hospitals with incentive payments for the quality
of care they provide,3 yet recent studies found little evidence
that public reporting of hospital quality measures4–6 and VBP
rewards lead to improved patient outcomes.7 To our knowl-
edge, no published studies have assessed infection control (IC)
measures and their correlation with other outcomes. The pri-
mary aim of this study was, therefore, to ascertain whether
hospitals that perform well in IC measures also perform well
on CMS non–IC quality measures.
methods
This cross-sectional study included 20 acute-care hospitals
from 16 states in the United States. A previous randomized
controlled trial (RCT) was conducted in 20 intensive care units
(ICUs) in 2012 to evaluate whether wearing gloves and gowns
for all patient contact decreased acquisition of methicillin-
resistant Staphylococcus aureus (MRSA) or vancomycin-
resistant Enterococcus (VRE).8 Data regarding the following
6 IC measures were collected as part of this previous RCT for
each ICU: (1) hand-hygiene compliance, (2) gown com-
pliance, (3) glove compliance, (4) central line-associated
bloodstream infection (CLABSI) rate, (5) catheter-associated
urinary tract infection (CAUTI) rate, and (6) VRE or MRSA
colonization acquisition rate.
The following 6 non–IC quality measures were selected by
author consensus upon review of the CMS Hospital Compare
program for the period available that was closest to 2012:
(1) rate of hospital-wide readmission, (2) rate of serious
complications, (3) nurse communication, (4) doctor com-
munication, (5) hospital recommendation, and (6) timely
venous thromboembolism prophylaxis.
Infection Control Measures
Hand-hygiene compliance was recorded as a proportion of
observed hand-hygiene events divided by the number of times
a healthcare worker exited a room. Compliance with glove and
gown use was measured in the same way. CLABSI and CAUTI
rates were calculated in accordance with National Healthcare
Safety Network definitions as cases per 1,000 patient days. VRE
or MRSA colonization acquisition data were obtained by active
surveillance culturing on ICU admission and discharge.8
CMS Non–Infection Control Quality Measures
Rate of readmission included all unplanned hospital-wide
30-day readmissions.9 The serious complications variable was
a composite of 11 measures from the Agency for Healthcare
Research and Quality Patient Safety Indicators and was based
on how often adult patients had certain serious but potentially
preventable complications.9 Nurse and doctor communication
and overall hospital recommendation were derived from linear
mean scores from the Hospital Consumer Assessment of
Healthcare Providers and Systems (HCAHPS) survey.9 The
venous thromboembolism variable from the Joint Commis-
sion describes the percentage of surgery patients who received
appropriate venous thromboembolism prophylaxis.9
Hospitals were assigned a rank for each variable. For VRE/
MRSA rate, CLABSI rate, CAUTI rate, rate of hospital-wide
readmission, and rate of serious complications, lower rate
values were assigned higher ranks (rank 1= best, rank
20=worst). Conversely, for hand-hygiene compliance, gown
compliance, glove compliance, nurse communication, doctor
communication, hospital recommendation, and timely venous
thromboembolism prophylaxis, higher values were assigned
higher ranks. To visually compare hospital performance,
overall ranks for a composite of the IC outcomes and a com-
posite of CMS non–IC quality measures were displayed gra-
phically. To statistically compare the correlation between
variables, Spearman’s rank-order correlation coefficients (rs)
were calculated for each variable pair. For this study, rs> 0.80
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or<− 0.80 was considered a strong correlation and rs between
0.50 and 0.80 or between −0.50 and −0.80 was considered a
moderate correlation.10
results
Hospitals that performed best on IC measures did not perform
well on most CMS non–IC quality measures (Figure 1). For
example, for overall IC scores versus the overall CMS non–IC
outcome category, the hospitals that ranked 1st, 2nd, and 3rd on
IC measures were ranked 10th, 5th, and 8th, respectively, on
CMS non–IC quality measures (Figure 1). Similarly, the top 3
hospitals for CMS non–IC quality measures were ranked 7th,
12th and 13th (tied for 2nd rank), and 9th for IC measures
(Figure 1). Overall, there were only 8 significant correlations
among 36 possible associations. We did not find any differ-
ences between the intervention group of the RCT compared to
the control group.
Correlations Between Infection Control Measures and CMS
Non–Infection Control Quality Measures
There were no strong correlations and only 2 moderate
correlations between IC measures and CMS non–IC quality
outcomes. Moderate correlations were observed between
hand-hygiene compliance and nurse communication
(rs= 0.53; P= .016) and between VRE or MRSA rate and rate
of readmission (rs= 0.53; P= .02) (Table 1).
Correlations Among Infection Control Measures
Among IC measures, there was 1 strong correlation and 2
moderate correlations. A strong correlation was observed
between glove compliance and gown compliance (rs = 0.92;
P ≤ .0001), and moderate correlations were observed between
hand-hygiene compliance and gown compliance (rs= 0.68;
P= .001) as well as hand-hygiene compliance and glove
compliance (rs= 0.56; P ≤ .01) (Table 1).
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figure 1. Hospital rankings by infection control measures and Centers for Medicare and Medicaid Services (CMS) non–infection control
quality measures.
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table 1. Correlations Between Infection Control Measures and Centers for Medicare and Medicaid Services (CMS) Non–Infection Control Measures
Spearman Correlation Coefficient (P Value)
Infection Control Measures CMS Non-Infection Control Quality Measures
Glove
Compliance
Gown
Compliance
HH
Compliance
(on room
exit)
CLABSI
Ratea
CAUTI
Ratea
VRE or
MRSA Ratea
Hospital-
wide
Readmission
Serious
Complications
RN
Communication
MD
Communication
Hospital
Recommend
VTE
Prophylaxis
Infection Control Measures
Glove compliance 1.00
Gown compliance .915 (< .0001) 1.00
HH compliance (on room exit) .557 (.011) .681 (.001) 1.00
CLABSI Ratea −.221 (.362) −.090 (.705) −.130 (.586) 1.00
CAUTI Ratea −.040 (.867) .059 (.803) −.083 (.729) .174 (.463) 1.00
VRE or MRSA Ratea .052 (0.828) 0.055 (.818) .138 (.561) .182 (.443) −.023 (.922) 1.00
CMS Non–Infection Control Quality Measures
Hospital-wide Readmission .258 (.272) .318 (.171) .297 (.203) .017 (.943) .231 (.328) .531 (.016) 1.00
Serious complications .183 (.468) .230 (.358) .306 (.217) .007 (.977) −.437 (.070) .207 (.411) .493 (.038) 1.00
RN communication .105 (.661) .232 (.323) .529 (.016) −.188 (.428) −.187 (.429) .043 (.856) .154 (.517) .456 (.038) 1.00
MD communication −.215 (.272) −.026 (.913) .230 (.329) −.039 (.869) −.018 (.429) −.188 (.427) .178 (.453) .401 (.099) .730 (.003) 1.00
Hospital Recommend .181 (.445) .292 (.212) .469 (.037) −.126 (.598) −.351 (.129) −.126 (.596) −.084 (.726) .487 (.041) .898 (<.0001) .696 (.0006) 1.00
VTE prophylaxis .099 (.695) .200 (.424) .284 (.254) −.211 (.400) .280 (.260) −.019 (.941) .138 (.584) .139 (.583) .067 (.792) .258 (.301) .093 (.715) 1.00
NOTE. HH, hand hygiene; CLABSI, central line-associated bloodstream infection; CAUTI, catheter-associated urinary tract infection; VRE, vancomycin-resistant Enterococcus; MRSA,
methicillin-resistant Staphylococcus aureus; RN, nurse; MD, doctor; VTE, venous thromboembolism.
Bold values indicate correlations where P< .05
aCases per 1,000 patient days.
738
in
fe
c
t
io
n
c
o
n
t
r
o
l
&
h
o
sp
it
a
l
e
p
id
e
m
io
lo
g
y
ju
n
e
20
17,
v
o
l.
38,
n
o
.
6
Correlations Between CMS Non–Infection Control Quality
Measures
Among CMS non–IC quality measures, there was 1 strong
correlation and 2 moderate correlations. A strong correlation
was observed between overall hospital recommendation and
nurse communication (rs= 0.90; P≤ .0001). Moderate
correlations were observed between overall hospital recom-
mendation and doctor communication (rs= 0.70; P= .0006)
as well as nurse communication and doctor communication
(rs = 0.73; P= .003) (Table 1).
discussion
The lack of correlations in our results reinforces the hypothesis
that there are hospital-level differences in IC measures and
other non–IC quality measures. These findings also suggest
that some of the metrics currently reported by CMS may not
appropriately depict hospital quality. This study provides
insights into the potential tradeoffs between IC measures and
other quality measures. The reasons for the lack of observed
correlations are likely multifactorial and may include the
following: (1) Hospitals have insufficient resources to tackle
multiple hospital quality measures and thus focus only on a
few. (2) Some hospital quality measures should be re-evaluated
regarding their causal relationship to quality. (3) Better risk
adjustment must be done for quality measures to ensure that
hospitals with complex patient populations are not inappro-
priately penalized for metrics such as infection rates.
This study has several limitations. First, it has cross-sectional
design, and measurement periods do not always overlap. Fur-
thermore, the IC measures were based solely on a single ICU,
whereas all non–IC measures from Hospital Compare were
based on whole-hospital performance. In addition, most hos-
pitals included were academic teaching centers; thus, these
results may not be generalizable to all hospitals.
Public reporting is an important part of hospital IC and
quality; however, presenting too many metrics can be con-
fusing to healthcare consumers and may not provide an
appropriate picture of hospital performance. In addition, the
potential pros and cons of value-based purchasing by CMS has
been heatedly debated. More work is needed to analyze the
outcomes and method of data presentation currently utilized
by the CMS. To fully optimize the VBP model, national efforts
that focus on patient experiences, such as the CMS VBP
program, must validate that they are rewarding quality instead
of inadvertently punishing high-performing hospitals that may
not perform well on certain measures.
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